Nav: Home

New research hopes to identify individuals at risk of clinically significant COPD

June 25, 2019

New research from the University of Alabama at Birmingham provides evidence, for the first time, for physicians to continue using the spirometry criteria set by major respiratory societies for the diagnosis of airflow obstruction and chronic obstructive pulmonary disease.

Published in the Journal of the American Medical Association, Surya Bhatt, M.D., associate professor in the Division of Pulmonary, Allergy and Critical Care Medicine and medical director of the UAB Pulmonary Function and Exercise Physiology Lab, says there is much confusion and debate in the medical community on what are the best spirometry criteria to use for diagnosing COPD.

Currently, major respiratory society guidelines recommend diagnosing airflow obstruction when the ratio of the forced expiratory volume in one second (FEV1) to the forced vital capacity (FVC) is less than a fixed threshold of 0.70. This means that, during a forced exhalation following a maximal inhalation, a normal individual should be able to blow out at least 70 percent of their lung size or vital capacity in the first second. However, there is no rigorous, population-based evidence to support the threshold of 0.70, which was set by expert opinion as the optimal FEV1/FVC threshold for defining clinically significant airflow obstruction, according to the published research.

"A diagnosis of COPD needs confirmation by demonstrating obstruction to airflow using spirometry," Bhatt said. "The currently used criteria are based on expert opinion, and until these results were published, there was not enough evidence to support their use."

The multisite team, led by researchers from UAB and the University of Columbia, analyzed data from a large, multi-ethnic sample of 24,207 adults in the United States, and found that the currently used threshold of 0.70 provided discrimination of COPD-related hospitalization and mortality that was not significantly different from -- or was more accurate than -- other fixed thresholds. The 0.70 threshold was also more accurate than other thresholds that define normal lung function and are derived from reference populations. These results support the continued use of FEV1/FVC <0.70 to identify individuals at risk of clinically significant COPD.

Cigarette smoking is the primary cause of COPD in the United States, but air pollutants at home (secondhand smoke and some heating fuels), at work (dusts, gases and fumes) and for those with genetic predisposition also can cause COPD. COPD makes breathing difficult for the estimated 14 million Americans who have this disease. Millions more suffer from COPD, but have not been diagnosed. Although there is no cure, it can be treated.

"The ongoing disagreement between experts on the best spirometry criteria to diagnose airflow obstruction has resulted in a lack of clarity for clinicians," Bhatt said. "Using a simple standard threshold has the potential to improve the diagnosis and treatment of this common disease."

According to the Centers for Disease Control and Prevention, Alabama has one of the highest rates of COPD. About 9.6 percent of Alabama residents surveyed in 2011 reported having been told by a health care professional that they have COPD. "The symptoms of COPD are often non-specific, and an accurate diagnosis will determine who gets appropriately treated, and is also important for avoiding unnecessary therapies," Bhatt said.
-end-


University of Alabama at Birmingham

Related Copd Articles:

COPD as a lung stem cell disease
Two internationally renowned stem cell researchers at the University of Houston have found an abundance of abnormal stem cells in the lungs of patients who suffer from Chronic Obstructive Pulmonary Disease (COPD), a leading cause of death worldwide.
New hope for COPD patients possible with in-home device
In a new paper published Feb. 4 in JAMA, Mayo Clinic researchers describe the benefits of in-home noninvasive ventilation therapy, which includes a type referred to as bilevel positive airway pressure, or BiPAP -- for many patients with chronic obstructive pulmonary disease (COPD).
COPD appears to cause more severe symptoms in women
Women who develop COPD report smoking fewer cigarettes than men; and yet, women experience greater breathing impairments, are subjected to more acute exacerbations of symptoms and report lower quality of life than men with the disease, according to research presented at ATS 2019.
African-Americans with COPD appear less likely to use pulmonary rehab
African-American patients with chronic obstructive pulmonary disease, or COPD, are less likely to participate in pulmonary rehabilitation programs than white patients, even when there are programs nearby.
COPD and type 2 diabetes
COPD and type 2 diabetes are two highly prevalent global health conditions associated with high mortality and morbidity.
Number of nonsmokers with COPD on the rise
The global burden of COPD is high, and prevalence of nonsmokers with COPD has been increasing.
Flu vaccination keeps COPD patients out of the hospital
A new study published in the January issue of CHEST® establishes that patients with chronic obstructive pulmonary disease (COPD) face heightened risks of death, critical illness, and hospitalization if they develop the flu and demonstrates the beneficial effects of influenza vaccination.
Kidney disease biomarker may also be a marker for COPD
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
COPD-associated inflammation halted in model experiment
Chronic obstructive pulmonary disease, or COPD for short, is believed to be the third most common cause of death worldwide.
Study: Almost 100 million adults have COPD in China
Chronic obstructive pulmonary disease (COPD) is widespread in China with 8.6 percent of the country's adult population -- almost 100 million people -- suffering from the chronic lung disease, according to a new Tulane University study published in The Lancet.
More COPD News and COPD Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.